Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION) Meeting Abstract
| Authors: | Morris, M. J.; De Bono, J. S.; Chi, K. N.; Fizazi, K.; Herrmann, K.; Rahbar, K.; Tagawa, S. T.; Nordquist, L. T.; Vaishampayan, N.; El-Haddad, G.; Park, C. H.; Beer, T. M.; Pérez-Contreras, W. J.; Desilvio, M.; Kpamegan, E. E.; Gericke, G.; Messmann, R. A.; Krause, B. J.; Sartor, A. O.; on behalf of the VISION Trial Investigators |
| Abstract Title: | Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION) |
| Meeting Title: | 57th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-06-20 |
| Language: | English |
| ACCESSION: | WOS:000707135200005 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.LBA4 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA4 -- Source: Wos |
